These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38801488)
21. Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer. Juracek J; Peltanova B; Dolezel J; Fedorko M; Pacik D; Radova L; Vesela P; Svoboda M; Slaby O; Stanik M J Cell Mol Med; 2018 Mar; 22(3):2033-2038. PubMed ID: 29363887 [TBL] [Abstract][Full Text] [Related]
22. Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma. Que R; Ding G; Chen J; Cao L World J Surg Oncol; 2013 Sep; 11():219. PubMed ID: 24007214 [TBL] [Abstract][Full Text] [Related]
23. Exosome-transmitted microRNA-133b inhibited bladder cancer proliferation by upregulating dual-specificity protein phosphatase 1. Cai X; Qu L; Yang J; Xu J; Sun L; Wei X; Qu X; Bai T; Guo Z; Zhu Y Cancer Med; 2020 Aug; 9(16):6009-6019. PubMed ID: 32627968 [TBL] [Abstract][Full Text] [Related]
24. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression. Zheng R; Du M; Wang X; Xu W; Liang J; Wang W; Lv Q; Qin C; Chu H; Wang M; Yuan L; Qian J; Zhang Z Mol Cancer; 2018 Oct; 17(1):143. PubMed ID: 30285771 [TBL] [Abstract][Full Text] [Related]
25. Urine micro-RNA signature as a potential non-invasive diagnostic biomarker in bladder cancer. Mamdouh S; Sherif H; Romeih M; Elesaily K Asian Pac J Cancer Prev; 2023 Jan; 24(1):121-131. PubMed ID: 36708560 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of serum exosomal LncRNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer. Zhang S; Du L; Wang L; Jiang X; Zhan Y; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Shi Y; Wang C J Cell Mol Med; 2019 Feb; 23(2):1396-1405. PubMed ID: 30467945 [TBL] [Abstract][Full Text] [Related]
27. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer. Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772 [TBL] [Abstract][Full Text] [Related]
28. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956 [TBL] [Abstract][Full Text] [Related]
29. Circulating exosomal miR-363-5p inhibits lymph node metastasis by downregulating PDGFB and serves as a potential noninvasive biomarker for breast cancer. Wang X; Qian T; Bao S; Zhao H; Chen H; Xing Z; Li Y; Zhang M; Meng X; Wang C; Wang J; Gao H; Liu J; Zhou M; Wang X Mol Oncol; 2021 Sep; 15(9):2466-2479. PubMed ID: 34058065 [TBL] [Abstract][Full Text] [Related]
30. Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study. Spagnuolo M; Costantini M; Ferriero M; Varmi M; Sperduti I; Regazzo G; Cicchillitti L; Díaz Méndez AB; Cigliana G; Pompeo V; Russo A; Laquintana V; Mastroianni R; Piaggio G; Anceschi U; Brassetti A; Bove A; Tuderti G; Flammia RS; Gallucci M; Simone G; Rizzo MG J Exp Clin Cancer Res; 2020 Apr; 39(1):68. PubMed ID: 32303246 [TBL] [Abstract][Full Text] [Related]
31. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer. Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526 [TBL] [Abstract][Full Text] [Related]
32. Urinary exosome miR-30c-5p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5. Song S; Long M; Yu G; Cheng Y; Yang Q; Liu J; Wang Y; Sheng J; Wang L; Wang Z; Xu B J Cell Mol Med; 2019 Oct; 23(10):6755-6765. PubMed ID: 31342628 [TBL] [Abstract][Full Text] [Related]
33. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder. Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881 [TBL] [Abstract][Full Text] [Related]
34. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis. Foj L; Ferrer F; Serra M; Arévalo A; Gavagnach M; Giménez N; Filella X Prostate; 2017 May; 77(6):573-583. PubMed ID: 27990656 [TBL] [Abstract][Full Text] [Related]
35. Tumor-derived circulating exosomal miR-342-5p and miR-574-5p as promising diagnostic biomarkers for early-stage Lung Adenocarcinoma. Han Z; Li Y; Zhang J; Guo C; Li Q; Zhang X; Lan Y; Gu W; Xing Z; Liang L; Li M; Mi S Int J Med Sci; 2020; 17(10):1428-1438. PubMed ID: 32624699 [TBL] [Abstract][Full Text] [Related]
36. Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection. Hirschfeld M; Rücker G; Weiß D; Berner K; Ritter A; Jäger M; Erbes T Mol Diagn Ther; 2020 Apr; 24(2):215-232. PubMed ID: 32112368 [TBL] [Abstract][Full Text] [Related]
37. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor. Warnecke-Eberz U; Chon SH; Hölscher AH; Drebber U; Bollschweiler E Tumour Biol; 2015 Jun; 36(6):4643-53. PubMed ID: 25631748 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic panel of serum miR-125b-5p, miR-182-5p, and miR-200c-3p as non-invasive biomarkers for urothelial bladder cancer. Wen Z; Huang G; Lai Y; Xiao L; Peng X; Liu K; Zhang C; Chen X; Li R; Li X; Lai Y; Ni L Clin Transl Oncol; 2022 May; 24(5):909-918. PubMed ID: 35028929 [TBL] [Abstract][Full Text] [Related]
39. Differential expression of urinary exosomal microRNAs in IgA nephropathy. Min QH; Chen XM; Zou YQ; Zhang J; Li J; Wang Y; Li SQ; Gao QF; Sun F; Liu J; Xu YM; Lin J; Huang LF; Huang B; Wang XZ J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28383146 [TBL] [Abstract][Full Text] [Related]
40. MiR-188-5p and MiR-141-3p influence prognosis of bladder cancer and promote bladder cancer synergistically. Yang X; Wang P Pathol Res Pract; 2019 Nov; 215(11):152598. PubMed ID: 31562019 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]